RT Journal Article SR Electronic T1 Simvastatin Inhibits Catecholamine Secretion and Synthesis Induced by Acetylcholine via Blocking Na+ and Ca2+ Influx in Bovine Adrenal Medullary Cells JF Journal of Pharmacology and Experimental Therapeutics JO J Pharmacol Exp Ther FD American Society for Pharmacology and Experimental Therapeutics SP 130 OP 136 DO 10.1124/jpet.108.139659 VO 327 IS 1 A1 Taeko Matsuda A1 Yumiko Toyohira A1 Susumu Ueno A1 Masato Tsutsui A1 Nobuyuki Yanagihara YR 2008 UL http://jpet.aspetjournals.org/content/327/1/130.abstract AB Simvastatin, an inhibitor of HMG-CoA reductase, is a potent inhibitor of cholesterol biosynthesis and has beneficial effects in the primary and secondary prevention of cardiovascular diseases. In this study, we report the effects of simvastatin on catecholamine secretion and synthesis in cultured bovine adrenal medullary cells used as a model of sympathetic neurons. Simvastatin inhibited catecholamine secretion induced by acetylcholine, an agonist of the nicotinic acetylcholine receptor; by veratridine, an activator of voltage-dependent Na+ channels; and by high K+, an activator of voltage-dependent Ca2+ channels (IC50 = 3.8, 7.8, and 6.1 μM, respectively). Simvastatin also suppressed acetylcholine-induced 22Na+ influx (IC50 = 4.3 μM) and 45Ca2+ influx (IC50 = 6.1 μM), veratridine-induced 22Na+ influx (IC50 = 6.6 μM) and 45Ca2+ influx (IC50 = 12 μM), and high K+-induced 45Ca2+ influx (IC50 = 11 μM). The reduction of catecholamine secretion caused by simvastatin was not overcome by increasing the concentration of acetylcholine or by treatment with mevalonate, the first metabolite of HMG-CoA. The inhibitory effect of simvastatin on histamine-induced secretion of catecholamines was observed in the presence of extracellular Ca2+, but not in a Ca2+-free medium, suggesting that simvastatin does not interfere with histamine receptors nonselectively. Simvastatin also suppressed acetylcholine-induced [14C]catecholamine synthesis from [14C]tyrosine as well as tyrosine hydroxylase activity. These findings suggest that simvastatin inhibits catecholamine secretion and synthesis induced by acetylcholine through suppression of Na+ and Ca2+ influx in the adrenal medulla and probably in the sympathetic neurons. The American Society for Pharmacology and Experimental Therapeutics